Recall
FDAHealthMarch 9, 2026

Zydus Pharmaceuticals (USA) Inc — Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA)

⚠️ Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 9, 2026

Nationwide in the USA

What's affected?

Product
Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7
UPC
0370710159276
Lot code
S2520249

Additional details

Lot #: S2520249, S2520250, S2520267, Exp. Date 2027/Jan; S2520303, S2520305, S2520332, Exp. Date 2027/Feb; S2540208, S2540209, Exp. Date 2027/Apr

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 60,541 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.